Medifast Reports Q1 2024 Results
April 29, 2024 Management said that: “Our new model is highly differentiated from competitors, with a holistic approach including our habit-based and Coach guided solution
Higher Quality Weight Loss Drugs Coming in the Future
April 29, 2024 According to an article at Biospace.com, GLP-1 agonists are set to become the best-selling drugs in 2024, but the biopharma industry isn’t
Telehealth Weight Loss Market Worth $6.9 Billion And Growing
April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for
Oprah’s TV Special Falls Short
March 19, 2024 Last night Oprah Winfrey hosted a TV special investigating the popular GLP-1 diet drugs. The stories by people who lost significant weight
Eli Lilly Offers Access To Zepbound via Amazon
March 14, 2024 The U.S. pharmaceutical giant Eli Lilly is partnering with Amazon to help distribute its prescription drugs, notably its new weight loss treatment
U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs
March 4, 2024 U.S. Weight Loss Market Now Worth $90 Billion, Obesity Drug Sales Soar March 4, 2024 Marketdata LLC has just published a new
Weight Watchers Reports Q4 and 2023 Results
Feb. 28, 2024 WW reported its results for Q4 2023 and the full year today. WW reported results in line with analysts’ expectations in Q4
Medifast Reports Q4 and Full Year 2023 Results
Feb. 20, 2024 Medifast reported full-year and Q4 results on February 20, 2023. 2023 revenues came in at $1.07 billion. The company employed 41,100 active